Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers (Phase I)
This study has been completed.
Sponsor:
Laurantis Pharma, Ltd.
Collaborator:
Kuopio University Hospital
Information provided by (Responsible Party):
Laurantis Pharma, Ltd.
ClinicalTrials.gov Identifier:
NCT01476332
First received: November 10, 2011
Last updated: May 15, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2012 |
| Primary Completion Date: | March 2012 (Final data collection date for primary outcome measure) |